This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
RIPAb+ PABPC1 - RIP Validated Antibody and Primer Set
catalog :
03-101
quantity :
10 assays
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
citations: 1
product information
Catalog Number :
03-101
Subcategory :
Epigenetics & Nuclear Function
Product Name :
RIPAb+ PABPC1 - RIP Validated Antibody and Primer Set
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P11940
Host Name :
Mouse
Antigen :
PABPC1
Conjugate :
Purified
Isotype :
IgG2b
Product Description :
RIPAb+ PABPC1 - RIP Validated Antibody and Primer Set
Cross Reactivity :
Human;Rabbit;Xenopus
Immunogen :
The PABPC1 monoclonal antibody is made against a fusion protein corresponding to full-length of human cytoplasmic poly (A)-binding protein (PABPC1).
Specificity :
PABPC1
Package Size :
10 assays
Uses :
RNA Binding Protein Immunoprecipitation (RIP);Immunoprecipitation;Western Blotting
Storage :
Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon first thaw, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments